In the Optimal Trial in Myocardial Infarction with the Angiotensin II Antagonist Losartan (OPTIMAAL), anemia was associated with HF on presentation and there was a clear trend to higher Killip classes in STEMI with lower hemoglobin levels [19] .
← all excerpts
Prevalence and prognostic significance of anemia in patients presenting for ST-elevation myocardial infarction in a Tunisian center.
2
—
—
The sentences
While there was a significant trend to less thrombolysis use in patients with lower baseline hemoglobin levels, pPCI was equally used in the different subgroups.